Versor Investments LP 13D and 13G filings for Intersect ENT, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-10 4:21 pm Sale |
2022-12-31 | 13G | Intersect ENT, Inc. XENT |
Versor Investments LP | 0 0.000% |
-3,347,165 (Position Closed) |
Filing |
| 2022-02-23 08:56 am Sale |
2022-02-14 | 13G | Intersect ENT, Inc. XENT |
Versor Investments LP | 3,347,165 10.000% |
-21,926 (-0.65%) |
Filing |
| 2022-02-17 11:40 am Purchase |
2022-02-07 | 13G | Intersect ENT, Inc. XENT |
Versor Investments LP | 3,369,091 10.070% |
193,994 (+6.11%) |
Filing |
| 2022-02-08 11:14 am Purchase |
2021-12-31 | 13G | Intersect ENT, Inc. XENT |
Versor Investments LP | 3,175,097 9.500% |
1,439,018 (+82.89%) |
Filing |
| 2021-08-17 3:21 pm Purchase |
2021-08-09 | 13G | Intersect ENT, Inc. XENT |
Versor Investments LP | 1,736,079 5.210% |
1,736,079 (New Position) |
Filing |